Drug Interactions between Iopidine and Mydfrin
This report displays the potential drug interactions for the following 2 drugs:
- Iopidine (apraclonidine ophthalmic)
- Mydfrin (phenylephrine ophthalmic)
Interactions between your drugs
No interactions were found between Iopidine and Mydfrin. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Iopidine
A total of 397 drugs are known to interact with Iopidine.
- Iopidine is in the drug class ophthalmic glaucoma agents.
- Iopidine is used to treat the following conditions:
Mydfrin
A total of 90 drugs are known to interact with Mydfrin.
- Mydfrin is in the following drug classes: mydriatics, ophthalmic antihistamines and decongestants.
- Mydfrin is used to treat the following conditions:
Drug and food interactions
apraclonidine ophthalmic food
Applies to: Iopidine (apraclonidine ophthalmic)
After using apraclonidine ophthalmic, some of the medication may be absorbed into the bloodstream and occasionally produce central nervous system side effects such as dizziness, drowsiness, and difficulty concentrating. Combining it with ethanol or other medications that can also have these effects may increase the risk. You should avoid or limit the use of alcohol while being treated with these medications. Also avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medications affect you, and use caution when getting up from a sitting or lying position. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Adrenergic antiglaucoma agents
Therapeutic duplication
The recommended maximum number of medicines in the 'adrenergic antiglaucoma agents' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'adrenergic antiglaucoma agents' category:
- Iopidine (apraclonidine ophthalmic)
- Mydfrin (phenylephrine ophthalmic)
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.